This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-small cell lung cancer, squamous, helper endpoint
HLP_C3_NSCLC_SQUAM
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
1956 |
4. Check minimum number of eventsNone |
1956 |
5. Include endpointsNone |
1956 |
6. Filter based on genotype QC (FinnGen only) |
1956 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, squamous, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, squamous
- Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)
- Non-small cell lung cancer
- Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of bronchus and lung
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1956 | 283 | 1673 |
| Unadjusted period prevalence (%) | 0.64 | 0.10 | 0.74 |
| Median age at first event (years) | 71.76 | 69.71 | 72.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1849
- Matched controls
- 18491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.2
323.0
941
1447
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
323.0
348
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
246.2
323.0
503
28
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.7
323.0
856
1095
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
20.9
323.0
591
407
130
Kela drug reimbursment
Malignant tumour
11.7
323.0
790
1105
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
186.9
323.0
670
56
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
9532.9
323.0
981
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
26.2
323.0
464
233
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
323.0
426
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
25.3
227.0
326
155
GDC00
NOMESCO Finland
Lobectomy of lung
57.6
185.3
219
43
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
122.3
184.2
197
18
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
24.1
183.0
266
128
L01CA04
ATC
vinorelbine; systemic
63.3
157.3
183
32
H02AB02
ATC
dexamethasone; systemic
6.3
146.3
439
875
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.0
138.0
710
2488
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
135.0
632
2025
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.9
134.7
198
96
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
39.9
121.5
154
42
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
115.5
119.7
129
12
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
135.1
118.7
126
10
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
24.4
117.3
169
76
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
12.1
104.7
198
181
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
22.4
96.9
143
69
WF004
NOMESCO Finland
Palliative radiotherapy
11.8
93.8
179
166
A04AA01
ATC
ondansetron; systemic, rectal
6.8
93.6
253
421
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.0
90.3
268
504
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
91.0
85.9
95
11
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
19.7
84.0
129
70
N02AA05
ATC
oxycodone; systemic
3.2
81.1
535
2109
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
102.6
80.7
88
9
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
12.5
80.4
149
129
WF049
NOMESCO Finland
Radiotherapy of metastasis
7.4
74.7
187
276
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
12.6
72.8
134
114
Z51.5
ICD-10 Finland
Palliative care
4.4
71.9
286
735
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
9.6
68.1
144
161
R03BB04
ATC
tiotropium bromide; inhalant
3.1
67.5
453
1775
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
11.0
66.8
131
127
GD1AD
NOMESCO Finland
Thorax CT examination
6.0
65.0
191
349
GDD00
NOMESCO Finland
Pneumonectomy
141.1
64.3
68
5
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
8.3
64.3
148
191
R04.2
ICD-10 Finland
Haemoptysis
5.4
63.7
204
414
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.6
61.1
102
69
5826
FHL
Lobectomy or bilobectomy
36.6
57.7
74
21
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
22.5
57.5
84
39
R84
ICPC
Malignant neoplasm bronchus/lung
29.0
57.4
78
28
H02AB06
ATC
prednisolone; systemic
2.2
57.4
971
6167
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
56.2
827
4910
WF002
NOMESCO Finland
Radical radiotherapy
4.6
56.0
210
503
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
17.8
53.7
85
50
A04AA55
ATC
palonosetron, combinations; systemic
13.2
52.1
93
74
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.6
51.5
157
299
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
51.3
49
*
TGD00
NOMESCO Finland
Needle biopsy of lung
26.3
51.0
71
28
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
23.0
49.1
71
32
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
17.2
47.6
76
46
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
46.4
258
865
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
76.5
46.2
52
7
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
13.4
45.8
81
63
A98
ICPC
Health maint/preventive medicine
0.5
44.9
815
11320
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
22.8
44.2
64
29
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.7
42.9
329
1361
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.9
40.4
176
482
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
10.0
37.9
77
80
R03AC02
ATC
salbutamol; inhalant
1.9
37.7
842
5621
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
37.6
36
*
J01MA14
ATC
moxifloxacin; systemic
3.0
37.4
243
900
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
12.6
36.6
66
54
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.6
35.2
170
507
JN4BD
NOMESCO Finland
Extensive body CT
2.6
34.7
277
1163
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.9
33.7
147
402
WZC30
NOMESCO Finland
Teaching
2.6
32.8
262
1097
J01MA12
ATC
levofloxacin; systemic
2.1
31.7
457
2543
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
31.7
117
274
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
25.0
31.5
44
18
N07BA03
ATC
varenicline; oral
5.9
31.2
90
160
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
18.2
31.0
48
27
5828
FHL
Pneumectomy
71.1
31.0
35
5
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
16.4
29.9
48
30
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
11.1
29.8
57
53
GEA00
NOMESCO Finland
Mediastinoscopy
27.2
29.3
40
15
A04AA02
ATC
granisetron; systemic, transdermal
3.6
29.2
139
409
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
6.6
28.0
73
114
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
27.9
230
975
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
27.9
345
1786
N06DX01
ATC
memantine; oral
0.2
27.6
20
1188
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.2
27.5
87
173
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
27.2
183
688
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.0
26.8
438
2538
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
24.4
25.7
36
15
GDC10
NOMESCO Finland
Bilobectomy of lung
45.0
25.6
31
7
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.2
25.4
99
245
1240
FHL
Bronchoscopy
4.9
25.0
84
179
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
43.5
24.6
30
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
24.3
476
2924
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.2
23.9
94
235
XG410
NOMESCO Finland
Flow-volume spirometry
3.4
23.6
117
356
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.6
23.4
55
74
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
17.5
23.1
36
21
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
7.9
23.1
53
69
N02AX02
ATC
tramadol; systemic, rectal
1.7
23.0
767
5522
R03BB01
ATC
ipratropium bromide; inhalant
2.4
23.0
203
891
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
22.9
312
1672
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
22.8
788
5726
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
232.7
22.7
23
*
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
+∞
21.9
21
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
0.5
21.6
262
4378
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
10.5
21.6
42
41
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
116.4
21.6
23
*
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
21.2
413
6102
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
20.9
329
5131
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
20.9
716
9304
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
4.4
20.8
77
182
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
30.4
20.6
27
9
N40
ICD-10 Finland
Hyperplasia of prostate
0.6
20.4
376
5645
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
20.3
28
1132
B02AA02
ATC
tranexamic acid; systemic
2.2
20.0
211
1009
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
19.7
22
1002
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
24.9
19.5
27
11
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.6
19.4
272
4389
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
19.3
115
2414
P20
ICPC
Memory disturbance
0.4
18.8
79
1889
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.1
18.7
73
182
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
33.2
18.0
23
7
JN4AD
NOMESCO Finland
Body CT examination
2.4
17.9
157
684
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
10.5
17.7
34
33
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
17.7
189
3296
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
96.0
17.6
19
*
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
96.0
17.6
19
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
17.5
80
229
J01AA02
ATC
doxycycline; systemic
1.6
17.4
1264
10734
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
18.8
17.3
26
14
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.4
17.3
62
143
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.4
17.1
84
255
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
7.8
17.1
39
51
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
16.9
96
323
N02AA01
ATC
morphine; systemic, rectal
3.8
16.9
72
195
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.3
16.7
44
71
WX250
NOMESCO Finland
Intercostal blockade
23.3
16.4
23
10
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
16.3
155
2806
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
9.3
16.2
33
36
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
15.9
149
671
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
15.9
73
211
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
15.8
116
2278
EB1AA
NOMESCO Finland
Tooth X-ray examination
0.6
15.7
312
4663
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.3
15.7
58
138
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
15.7
334
2071
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.6
15.6
121
493
XKD00
NOMESCO Finland
Uroflowmetry
0.5
15.5
193
3242
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
15.4
182
913
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
5.0
15.4
49
100
A04AD12
ATC
aprepitant; systemic
6.6
15.4
39
60
Z72.0
ICD-10 Finland
Tobacco use
4.6
15.4
53
118
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.5
15.3
115
2244
ZX070
NOMESCO Finland
Intensity modified radiotherapy
4.2
15.3
58
142
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
10.5
15.2
29
28
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
15.2
210
1121
F03
ICD-10 Finland
Unspecified dementia
0.3
15.2
24
901
C10AA05
ATC
atorvastatin; oral
0.6
14.9
387
5461
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
15.2
14.9
24
16
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.5
14.9
26
21
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.5
14.9
123
2330
K02.1
ICD-10 Finland
Caries of dentine
0.6
14.7
306
4535
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.8
14.6
33
43
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
14.6
178
3011
L03AA13
ATC
pegfilgrastim; parenteral
3.7
14.3
63
176
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
14.1
9
583
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
14.5
14.1
23
16
ZX120
NOMESCO Finland
Intravenous
2.0
14.0
188
993
1CD01
NOMESCO Finland
NA
17.7
13.8
21
12
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.3
13.7
70
220
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.0
13.7
55
142
KMAK
NOMESCO Finland
NA
0.6
13.7
285
4237
PJD99
NOMESCO Finland
Excision of other lymph nodes
75.7
13.6
15
*
N06DA02
ATC
donepezil; oral
0.3
13.5
30
954
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
13.5
254
1511
L15
ICPC
Knee symptom/complaint
0.4
13.1
74
1594
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
12.2
13.1
23
19
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.4
12.9
65
1459
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
12.9
72
1559
1BC05
NOMESCO Finland
NA
50.3
12.8
15
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
12.6
15
662
R85
ICPC
Malignant neopl respiratory other
32.2
12.6
16
5
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.0
12.6
34
58
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.6
12.5
158
2662
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.6
12.5
267
3956
SPAT1301
SPAT
No procedures
0.6
12.4
253
3788
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
6.5
12.3
31
48
SDA01
NOMESCO Finland
Simple parodonthologic therapy
0.5
12.3
79
1625
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
12.3
634
4862
S18
ICPC
Laceration/cut
0.6
12.2
344
4811
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
16.0
12.1
19
12
VALMI
NOMESCO Finland
NA
0.5
12.1
78
1604
191
Kela drug reimbursment
Erlotinib
12.5
12.1
21
17
J01FA06
ATC
roxithromycin; oral
1.5
12.1
600
4557
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.7
12.0
25
29
H81
ICPC
Excessive ear wax
0.5
12.0
114
2074
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
11.9
234
3534
A06AH03
ATC
naloxegol; oral
5.3
11.8
35
67
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
4.8
11.7
38
81
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.8
11.7
38
81
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.6
11.6
85
339
L57.0
ICD-10 Finland
Actinic keratosis
0.4
11.6
56
1277
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
19.0
11.6
17
9
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.0
11.6
36
73
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
9.3
11.5
23
25
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
11.5
11
*
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
0.5
11.4
109
1985
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
0.5
11.4
89
1720
Z01.2
ICD-10 Finland
Dental examination
0.6
11.4
183
2902
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
11.3
7
463
R03DA04
ATC
theophylline; systemic, rectal
1.8
11.2
209
1239
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
3.7
11.2
48
133
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
11.2
162
2634
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
0.6
10.9
134
2276
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
43.6
10.9
13
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
10.9
63
1344
A02BX02
ATC
sucralfate; oral
2.2
10.9
108
503
J43.9
ICD-10 Finland
Emphysema, unspecified
2.9
10.8
64
226
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
0.5
10.8
77
1534
GAA31
NOMESCO Finland
Thoracoscopy
9.6
10.7
21
22
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
60.3
10.6
12
*
J86.9
ICD-10 Finland
Pyothorax without fistula
4.7
10.6
35
76
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
10.6
329
4539
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
10.5
108
512
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
0.6
10.4
146
2399
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
10.4
10
*
SPAT1153
SPAT
Removal of sutures
0.6
10.3
240
3511
GDA10
NOMESCO Finland
Biopsy of lung
12.1
10.3
18
15
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
10.3
*
346
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.1
10.3
*
318
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
10.3
21
694
TGC00
NOMESCO Finland
Bronchial lavation
2.9
10.2
61
216
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
23.5
10.2
14
6
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
0.6
10.2
212
3177
SPAT1053
SPAT
Memory test
0.6
10.1
147
2395
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
5.9
10.1
27
46
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
5.4
10.1
29
54
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.4
10.1
48
1100
D01AE16
ATC
amorolfine; topical
0.4
10.1
52
1156
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.4
10.0
40
979
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
0.7
10.0
388
5153
D19
ICPC
Teeth/gum symptom/complaint
0.5
10.0
89
1656
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
14.7
10.0
16
11
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
40.3
10.0
12
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
16.8
9.9
15
9
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
16.8
9.9
15
9
ZX050
NOMESCO Finland
Stereotactic radiotherapy
4.8
9.8
31
65
XG460
NOMESCO Finland
Short time oxymetry
2.7
9.8
63
235
H13
ICPC
Plugged feeling ear
0.6
9.7
127
2122
UGC02
NOMESCO Finland
Rigid bronchoscopy
13.4
9.7
16
12
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.8
9.7
26
45
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.4
9.6
51
1122
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.7
9.6
64
242
C10AA07
ATC
rosuvastatin; oral
0.6
9.5
154
2448
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.9
9.5
38
100
UKC02
NOMESCO Finland
Cystoscopy
0.6
9.5
206
3064
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
0.6
9.5
210
3111
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.7
9.5
355
4748
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
9.5
449
5773
SPAT1043
SPAT
Audiometry
0.5
9.4
56
1187
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.3
9.4
46
143
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
5.4
9.4
27
51
C08CA01
ATC
amlodipine; oral
0.7
9.3
399
5222
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
9.6
9.3
18
19
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
9.2
207
3059
G04CA02
ATC
tamsulosin; oral
0.7
9.2
483
6115
M01AX05
ATC
glucosamine; oral
0.6
9.2
139
2240
J93.8
ICD-10 Finland
Other pneumothorax
6.7
9.1
22
33
R33
ICD-10 Finland
Retention of urine
0.5
9.1
101
1766
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
8.3
9.1
19
23
TGA30
NOMESCO Finland
Thoracocentesis
3.9
9.0
35
90
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.1
9.0
21
30
L01XE03
ATC
[U] erlotinib; oral
10.1
9.0
17
17
-1
NOMESCO Finland
NA
0.6
9.0
151
2382
XJH00
NOMESCO Finland
Transanal ultrasonography
0.5
9.0
70
1356
C09AA02
ATC
enalapril; systemic
0.7
8.9
246
3489
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.8
8.9
57
211
116
Kela drug reimbursment
Prostate cancer
0.5
8.9
76
1434
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
8.9
295
4040
D82
ICPC
Teeth/gum disease
0.6
8.8
141
2250
R95
ICPC
Chron obstructive pulmonary disease
2.4
8.8
71
302
R24
ICPC
Haemoptysis
5.6
8.7
24
43
A02BA02
ATC
ranitidine; systemic
1.5
8.7
378
2768
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.7
8.6
36
99
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
8.6
32
803
C10AA01
ATC
simvastatin; oral
0.7
8.6
612
7421
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
8.5
102
1748
H02
ICPC
Hearing complaint
0.5
8.4
74
1382
WX330
NOMESCO Finland
Paravertebral ansthesia
90.4
8.4
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.3
8.4
76
341
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
7.9
8.4
18
23
M01AH05
ATC
etoricoxib; oral
0.7
8.3
396
5109
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.5
8.3
64
266
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.5
8.2
50
1050
G04CA01
ATC
alfuzosin; oral
0.6
8.1
149
2303
5188X
ICD-9 Finland
Other diseases of lung
4.9
8.1
25
52
SDA02
NOMESCO Finland
Parodonthologic therapy
0.6
8.0
152
2334
R06.0
ICD-10 Finland
Dyspnoea
1.4
8.0
420
3182
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
8.0
389
5010
N02BE01
ATC
paracetamol; systemic, rectal
0.8
8.0
1036
11619
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
8.0
77
1397
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.5
7.9
87
1527
G04BD12
ATC
mirabegron; oral
0.5
7.9
50
1036
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.6
7.9
91
1574
R31
ICD-10 Finland
Unspecified haematuria
0.6
7.8
117
1898
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
7.8
28
716
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
45.2
7.7
9
*
R05CB01
ATC
acetylcysteine; inhalant, oral
2.4
7.7
60
250
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
7.7
*
273
WW200
SPAT
NA
0.3
7.7
17
537
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
7.6
357
2646
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.3
7.6
68
304
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
11.9
7.6
13
11
114
Kela drug reimbursment
Glaucoma
0.5
7.6
73
1330
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.5
7.6
83
1458
GAC00
NOMESCO Finland
Biopsy of pleura
5.4
7.5
21
39
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.7
7.5
24
52
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
7.1
7.5
17
24
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
7.5
51
1028
R53
ICD-10 Finland
Malaise and fatigue
0.6
7.5
168
2485
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.8
7.5
44
157
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.1
7.4
38
124
N02AC04
ATC
dextropropoxyphene; oral
1.9
7.4
110
605
1440
FHL
Mediastinoscopy
10.9
7.3
13
12
M79.6
ICD-10 Finland
Pain in limb
0.7
7.2
239
3290
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
0.6
7.2
104
1703
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.6
7.2
139
2124
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
20.1
7.1
10
5
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.4
7.1
32
95
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
3.4
7.1
32
95
I25
ICD-10 Finland
Chronic ischaemic heart disease
0.4
7.1
31
730
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
0.2
7.0
9
378
R81
ICPC
Pneumonia
2.4
7.0
57
245
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
0.4
7.0
23
609
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.0
108
1740
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.9
6.9
40
140
I50.0
ICD-10 Finland
Congestive heart failure
0.6
6.9
101
1648
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
13.8
6.9
11
8
N06DA04
ATC
galantamine; oral
0.2
6.9
6
316
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.8
354
2668
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
6.7
6.8
16
24
KED22
NOMESCO Finland
Transurethral resection of prostate
0.6
6.8
90
1505
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.9
6.8
39
136
GDB20
NOMESCO Finland
Segmental resection of lung
40.2
6.8
8
*
S29
ICPC
Skin symptom/complaint other
0.6
6.8
93
1541
JN5AP
NOMESCO Finland
Total body PET (1 picture)
16.7
6.7
10
6
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
16.7
6.7
10
6
J93.9
ICD-10 Finland
Pneumothorax, unspecified
4.7
6.7
21
45
J01DB01
ATC
cefalexin; oral
0.8
6.7
910
10272
N05AX08
ATC
risperidone; systemic
0.5
6.7
55
1050
C09CA01
ATC
losartan; oral
0.7
6.7
205
2861
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
4.4
6.7
22
50
SPAT1325
SPAT
Vaccination
0.7
6.6
351
4484
SPAT1109
SPAT
Analgesia with portable analgesic pump
5.5
6.6
18
33
WX600
NOMESCO Finland
Single shot through catheter
4.6
6.6
21
46
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
12.3
6.6
11
9
J94.8
ICD-10 Finland
Other specified pleural conditions
2.5
6.6
47
189
J01MA02
ATC
ciprofloxacin; systemic
0.8
6.6
459
5641
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
6.6
138
2077
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.6
964
8478
N05BA04
ATC
oxazepam; oral
1.4
6.6
349
2644
Z57.2
ICD-10 Finland
Occupational exposure to dust
6.9
6.5
15
22
D01BA02
ATC
terbinafine; oral; topical
0.7
6.4
189
2658
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.4
6.4
31
705
P70
ICPC
Dementia
0.2
6.4
5
280
205
Kela drug reimbursment
Chronic hypertension
0.8
6.4
442
5442
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.0
6.3
80
415
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
2.1
6.3
69
339
S01ED51
ATC
timolol, combinations; ophthalmic
0.5
6.3
53
1000
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
0.4
6.3
26
628
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.4
6.3
51
219
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.6
6.3
138
2053
GBA22
NOMESCO Finland
Endoscopic excision of lesion of trachea
+∞
6.3
6
*
L01XE13
ATC
[U] afatinib; oral
+∞
6.3
6
*
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.2
6.2
30
95
UJF32
NOMESCO Finland
Coloscopy
0.7
6.2
233
3146
JN6AD
NOMESCO Finland
CT of torso and neck
4.1
6.2
22
54
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
7.7
6.1
13
17
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.4
6.1
20
527
L02AE02
ATC
leuprorelin; implant, parenteral
0.5
6.1
48
928
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
8.6
6.1
12
14
J01CA08
ATC
pivmecillinam; oral
0.7
6.0
144
2109
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
298
204
17.05
307.65
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
248
371
7.51
161.35
1.3
1.5
—
—
—
0
0
(4035726)
422
1065
4.78
157.13
1.5
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
255
627
4.53
95.81
2.1
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
100
110
9.53
83.08
1.8
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
143
242
6.30
81.69
1.9
2.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
691
10958
0.43
67.77
6.0
6.8
mmol/mol
42.6
41.6
1.70
604
9822
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
743
11316
0.45
63.02
4.1
5.4
mmol/l
2.4
2.4
0.01
627
10062
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
132
265
5.27
62.70
1.3
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
706
10946
0.44
62.54
3.7
4.7
mmol/l
4.2
4.2
0.21
606
9788
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
694
10802
0.45
61.65
3.7
4.7
mmol/l
1.3
1.4
2.39
585
9561
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
681
10465
0.46
55.13
3.4
4.2
mmol/l
1.3
1.3
1.57
571
9190
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
779
11315
0.48
52.07
5.3
5.1
mmol/l
6.2
6.2
0.46
674
9929
(3010813) Leukocytes [#/volume] in Blood
936
12691
0.50
49.34
43.0
27.7
e9/l
8.5
7.1
22.55
906
12123
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
460
7971
0.45
49.24
4.0
5.5
ug/l
2.4
5.0
4.22
386
6944
(3000963) Hemoglobin [Mass/volume] in Blood
936
12686
0.50
49.18
43.2
27.9
g/l
125.1
132.0
32.14
915
12312
(3026361) Erythrocytes [#/volume] in Blood
936
12685
0.50
49.15
42.9
27.7
e12/l
4.2
4.4
12.19
903
12115
(3035941) MCH [Entitic mass]
936
12684
0.50
49.11
42.7
27.6
pg
29.9
30.6
15.32
916
12310
(3024731) MCV [Entitic volume]
936
12684
0.50
49.11
42.8
27.6
fl
91.5
92.1
2.60
916
12311
(3007461) Platelets [#/volume] in Blood
936
12682
0.50
49.05
43.0
27.7
e9/l
278.8
229.8
47.61
908
12177
(3023103) Potassium [Moles/volume] in Serum or Plasma
935
12540
0.51
44.98
31.7
23.1
mmol/l
4.0
4.0
0.49
912
12081
(3019550) Sodium [Moles/volume] in Serum or Plasma
935
12526
0.51
44.56
31.9
22.9
mmol/l
138.4
139.6
28.01
913
12088
(3020564) Creatinine [Moles/volume] in Serum or Plasma
914
12289
0.52
43.31
35.4
22.6
umol/l
81.5
92.7
20.77
914
12282
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
914
12231
0.53
41.66
18.1
11.1
u/l
22.3
25.0
2.94
897
11570
(40761511) CBC panel - Blood by Automated count
887
11926
0.53
40.22
27.4
18.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
354
6407
0.45
39.57
3.8
4.8
%
21.6
22.2
0.33
165
3411
(3036481) Cortisol [Moles/volume] in Serum or Plasma
238
973
2.65
38.54
6.7
2.0
nmol/l
427.6
374.4
3.04
231
868
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
732
10348
0.53
38.13
5.8
4.3
mu/l
2.0
2.1
0.53
656
9054
(3009214) Lutropin [Units/volume] in Serum or Plasma
79
165
4.95
35.75
1.3
1.2
u/l
14.2
8.5
2.53
65
131
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
794
10817
0.55
34.69
28.6
18.3
ml/min/173m2
77.4
69.4
25.59
716
9013
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
355
6133
0.49
33.02
1.8
2.2
pmol/l
86.4
90.6
1.08
207
3351
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
27
16
17.10
32.43
1.0
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
320
1611
2.18
32.16
2.7
3.8
ug/l
8.3
27.2
2.21
293
1363
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
224
4516
0.43
31.46
2.8
3.3
ug/l
0.8
0.9
1.42
149
3240
(3012095) Magnesium [Moles/volume] in Serum or Plasma
416
2329
2.00
31.39
3.9
2.9
mmol/l
0.8
0.8
10.59
404
2142
(40768806) Pleura Pathology biopsy report
95
255
3.86
31.15
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
933
11854
0.59
27.70
32.7
19.2
mg/l
43.4
30.4
21.12
898
9922
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
59
126
4.80
26.02
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
111
2804
0.36
25.70
1.6
1.6
mmol/l
1.5
1.3
1.83
94
2279
(3023419) Bacteria identified in Sputum by Culture
76
208
3.76
24.26
2.1
2.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
759
9946
0.61
23.41
30.1
20.5
%
37.7
37.9
0.16
449
5749
(3003338) MCHC [Mass/volume]
680
9087
0.61
22.29
40.5
25.4
g/l
327.1
331.4
28.71
670
8917
(4010399)
186
873
2.25
21.87
1.3
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
97
335
2.99
21.42
1.4
1.5
g/l
37.2
29.8
8.58
89
300
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
288
4735
0.54
20.37
1.8
2.1
nmol/l
75.0
78.1
1.00
250
4043
(3037467) Urinalysis macro (dipstick) panel - Urine
663
8779
0.63
19.90
4.7
4.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
699
9146
0.63
19.88
36.6
23.1
%
14.8
14.1
28.82
685
8857
(3021960) Folate [Moles/volume] in Serum or Plasma
206
3712
0.50
19.44
1.4
1.6
nmol/l
18.5
19.1
0.26
175
3165
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
61
5.82
19.33
1.2
1.3
iu/l
18.0
25.6
0.75
25
52
(3044889) 12 lead EKG panel
653
8641
0.63
19.30
4.9
4.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
148
2958
0.46
18.78
3.3
3.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
80
270
3.05
18.40
1.4
1.4
e6/l
15469.2
61894.6
2.13
51
163
(3012441) Differential panel - Pleural fluid
77
255
3.10
18.30
1.4
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
327
5064
0.57
18.24
2.5
2.9
ug/l
250.0
177.1
2.98
294
4512
(3023199) Leukocytes [#/volume] in Pleural fluid
84
293
2.95
18.24
1.4
1.5
e6/l
1626.3
1980.1
0.35
63
211
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
614
8137
0.64
17.63
5.0
3.4
pmol/l
15.4
15.1
1.41
557
7071
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
319
1962
1.75
16.95
4.3
3.7
u/l
222.7
248.1
3.38
309
1819
(3009261) Glucose [Presence] in Urine by Test strip
421
6028
0.62
16.83
3.9
4.0
estimate
0.0
0.0
0.00
96
1104
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
59
175
3.45
16.77
1.2
1.3
u/l
9.3
15.6
1.73
59
163
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
62
194
3.27
16.21
2.7
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
267
4222
0.57
15.64
2.8
3.2
mmol/l
7.4
7.5
0.15
201
3436
(3035350) Ketones [Presence] in Urine by Test strip
421
5953
0.63
15.63
3.9
3.9
estimate
0.0
0.0
0.00
100
1147
(3020682) Albumin/Creatinine [Ratio] in Urine
291
4495
0.59
15.57
3.6
4.0
mg/mmol
13.2
10.6
0.35
184
2974
(3021601) Nitrite [Presence] in Urine by Test strip
419
5921
0.63
15.47
5.2
5.3
estimate
0.0
0.0
0.00
102
1140
(3012516) Albumin [Mass/volume] in Urine
268
4208
0.58
15.21
2.9
3.3
mg/l
427.6
262.1
0.30
181
2825
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
53
159
3.40
14.83
1.3
1.4
u/l
11.4
14.3
3.04
53
147
(3026493) Urate [Moles/volume] in Serum or Plasma
224
3669
0.56
14.81
2.6
3.0
umol/l
368.4
7421.0
13.04
177
3066
(3031040) Bacteria [#/volume] in Urine by Automated count
707
8766
0.70
12.68
4.4
4.9
e6/l
161.6
2413.7
2.16
17
197
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
319
4626
0.63
12.64
4.3
4.3
—
—
—
0
0
(3035880) pH of Pleural fluid
44
135
3.31
11.93
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
62
232
2.73
11.91
1.4
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
146
788
1.92
11.75
2.0
1.8
ug/l
1.3
2.9
1.04
131
678
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
204
3244
0.59
11.73
1.6
1.8
pmol/l
437.2
16149245.7
1.68
172
2607
(3001893) Eosinophils/100 leukocytes in Pleural fluid
32
81
4.00
11.48
1.3
1.6
%
1.5
2.5
0.34
26
66
(3023368) Bacteria identified in Blood by Culture
623
4856
1.42
10.90
4.8
4.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
284
4096
0.64
10.67
2.1
2.3
mg/l
3.5
3.1
1.12
244
3415
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
79
352
2.30
10.55
1.3
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
75
329
2.33
10.38
1.3
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
49
175
2.85
10.31
1.6
1.6
iu/l
2.4
5.5
2.07
12
47
(3030905) Polymorphonuclear cells [#/volume] in Blood
56
222
2.57
9.66
3.2
3.0
e9/l
6.0
4.7
2.92
56
222
(42870588) Differential panel, method unspecified - Blood
556
4326
1.40
9.59
7.0
5.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
61
253
2.46
9.58
1.3
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
213
3163
0.63
8.95
3.7
3.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
592
4704
1.37
8.86
2.7
2.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
56
233
2.44
8.76
3.6
3.4
%
65.8
60.4
2.44
56
233
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
52
209
2.53
8.75
1.3
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
532
4162
1.38
8.75
5.0
4.1
ph
7.4
7.4
0.03
98
804
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
543
6752
0.73
8.69
4.6
3.2
u/l
67.7
61.1
0.43
507
6072
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
105
1847
0.54
8.55
1.2
1.2
u/ml
2.1
1.6
0.17
26
452
(3021387) Prolactin [Units/volume] in Serum or Plasma
37
126
2.97
8.52
1.2
1.7
mu/l
281.1
283.9
0.03
37
118
(3019309) Folate [Moles/volume] in Red Blood Cells
248
3521
0.66
8.37
1.8
1.9
nmol/l
1031.5
1150.0
1.32
189
2598
(3022096) Basophils/100 leukocytes in Blood
682
5583
1.34
8.29
7.1
5.5
%
0.6
0.6
0.61
664
5144
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
135
2.85
8.13
1.1
1.7
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
698
5750
1.33
8.08
7.6
5.8
%
9.1
9.1
0.10
680
5306
(3006504) Eosinophils/100 leukocytes in Blood
693
5728
1.32
7.76
7.3
5.5
%
2.4
2.9
8.36
674
5266
(44790048)
39
146
2.71
7.59
1.2
1.5
—
—
—
0
0
(44806118)
39
146
2.71
7.59
1.2
1.5
—
—
—
0
0
(44790049)
39
146
2.71
7.59
1.2
1.5
—
—
—
0
0
(44790047)
39
146
2.71
7.59
1.2
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
721
6009
1.32
7.57
7.2
5.2
e9/l
0.7
0.6
12.76
646
5072
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
33
113
2.95
7.55
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
724
6046
1.31
7.46
7.2
5.2
e9/l
0.0
0.0
2.65
650
5120
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
142
2.71
7.43
1.1
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
183
2704
0.64
7.40
4.6
4.4
kg/l
1.0
1.0
0.48
31
439
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
391
5020
0.72
7.39
2.5
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
244
3394
0.68
7.31
4.2
4.3
estimate
0.0
0.0
0.42
82
1039
(3002030) Lymphocytes/100 leukocytes in Blood
701
5845
1.31
7.26
7.4
5.8
%
20.9
24.7
17.26
678
5350
(3015736) pH of Urine
357
4635
0.72
7.20
3.6
3.7
—
6.1
—
0
5
(3026008) Bacteria identified in Urine by Culture
324
4261
0.71
7.05
3.1
3.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
144
902
1.64
7.03
5.9
6.9
mmol/l
25.6
24.5
2.78
144
890
(3007164) IgA [Mass/volume] in Serum or Plasma
104
1734
0.58
6.96
1.4
1.5
g/l
3.4
3.0
0.89
58
994
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
29
97
3.02
6.93
1.3
1.6
%
66.5
69.5
0.18
24
74
(3013512) EKG study
328
4294
0.72
6.92
4.4
4.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
155
993
1.61
6.91
1.6
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
769
8915
0.77
6.90
5.7
4.1
mm/h
26.0
15.3
28.61
731
8057
(3003396) Base excess in Arterial blood by calculation
270
1950
1.45
6.88
6.3
6.4
mmol/l
1.8
1.1
2.46
224
1470
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
99
1660
0.57
6.77
3.3
4.8
%
33.5
33.0
0.19
67
1082
(3027801) Oxygen [Partial pressure] in Arterial blood
269
1948
1.44
6.75
6.3
6.4
kpa
10.3
11.5
5.49
258
1834
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
269
1948
1.44
6.75
6.3
6.4
kpa
5.4
5.0
4.14
257
1831
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
30
104
2.91
6.75
2.9
3.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
735
6221
1.29
6.65
7.6
5.4
e9/l
0.2
0.2
1.37
658
5354
(3019198) Lymphocytes [#/volume] in Blood
727
6148
1.29
6.61
7.3
5.4
e9/l
1.6
1.9
2.80
653
5298
(3004588) Protein electrophoresis panel - Serum or Plasma
67
1243
0.52
6.51
1.9
2.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
680
5748
1.28
6.08
7.1
5.5
%
63.5
59.6
13.30
658
5306
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
98
579
1.73
5.98
1.9
2.1
ug/l
210.6
691.4
2.53
90
547
(3013650) Neutrophils [#/volume] in Blood by Automated count
807
6980
1.27
5.94
15.1
8.2
e9/l
5.3
4.5
10.23
741
6017
(3011397) Hemoglobin [Presence] in Urine by Test strip
203
2818
0.69
5.92
4.0
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
171
1167
1.51
5.80
5.8
4.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
138
901
1.57
5.72
5.5
8.1
mmol/l
24.7
24.2
1.39
132
823
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
50
240
2.11
5.71
1.4
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
351
2754
1.33
5.38
2.0
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
277
2098
1.37
5.34
1.6
2.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
237
1751
1.40
5.31
6.7
6.7
%
94.0
95.0
1.09
229
1676
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
155
2216
0.67
5.27
2.1
2.7
%
17.2
22.1
5.58
130
1863
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
45
216
2.11
5.17
1.5
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
177
2.23
5.14
2.6
4.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
379
3026
1.31
5.13
11.4
6.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
38
171
2.25
5.11
1.3
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
165
2317
0.69
5.09
2.1
2.6
g/l
2.1
2.2
0.36
155
2109
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
115
1727
0.65
4.97
13.8
9.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
182
2499
0.70
4.96
2.1
2.7
umol/l
9.1
11.9
8.99
173
2275
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
108
690
1.60
4.94
2.2
2.5
u/ml
0.3
0.3
3.71
63
389
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
31
131
2.39
4.82
1.1
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
203
2.09
4.76
1.5
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
208
1545
1.39
4.52
7.3
7.2
g/l
120.6
120.1
0.15
202
1492
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
500
5889
0.80
4.51
4.7
4.5
ng/l
45.0
102.2
1.19
424
4725
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
40
194
2.08
4.51
1.5
1.5
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
14
39
3.61
4.48
1.4
1.9
%
2.2
3.2
—
9
17
(3027315) Oxygen [Partial pressure] in Blood
66
383
1.75
4.37
5.6
5.1
kpa
7.9
8.2
0.77
66
371
(1616796) Gas panel - Central venous blood
65
376
1.75
4.36
4.5
4.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
65
381
1.73
4.17
5.6
5.1
mmol/l
3.3
2.3
1.78
53
253
(3013290) Carbon dioxide [Partial pressure] in Blood
65
382
1.73
4.14
5.6
5.1
kpa
5.2
5.0
1.14
65
371
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
685
0.50
4.11
2.1
2.4
g/l
8.5
7.4
2.30
27
484
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
684
0.50
4.09
2.1
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
684
0.50
4.09
2.1
2.4
g/l
4.5
3.8
0.57
27
467
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
243
1881
1.33
4.07
1.8
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
82
1262
0.63
4.00
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
243
1887
1.33
3.98
1.8
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
208
0.24
3.97
1.0
1.1
—
17.2
—
0
10
(3039443) Prostate specific Ag panel - Serum or Plasma
6
226
0.26
3.91
1.2
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
429
5070
0.80
3.89
3.6
4.1
e6/l
44.0
132.7
4.84
344
3888
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
896
9847
0.83
3.84
14.2
7.6
u/l
86.0
83.8
0.59
876
9137
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
107
2.35
3.83
1.3
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
95
1401
0.66
3.80
1.2
1.2
u/ml
23.1
15.9
0.22
21
467
(36660697) Celiac disease serology panel - Serum
34
651
0.51
3.75
1.2
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
729
6464
1.20
3.75
7.5
6.1
mmol/l
1.2
1.2
8.97
694
5765
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
942
0.60
3.58
1.7
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
59
951
0.61
3.54
3.4
3.0
e6/l
0.6
0.3
0.56
59
934
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
624
0.52
3.52
2.2
2.5
g/l
3.4
3.1
0.93
27
478
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
621
0.52
3.47
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
349
0.37
3.46
1.3
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
466
5404
0.82
3.45
3.3
3.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
69
1063
0.64
3.41
2.0
2.1
nmol/l
11.0
11.7
0.29
58
896
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
642
0.54
3.39
2.1
2.5
g/l
9.8
10.5
0.57
28
533
(3010421) pH of Blood
70
444
1.60
3.39
5.6
4.8
ph
7.4
7.4
1.23
65
370
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
19
76
2.51
3.38
1.5
2.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
204
2596
0.76
3.38
26.2
30.4
inr
1.4
1.6
0.62
32
356
(3009343) pH of Capillary blood
151
1120
1.38
3.36
4.0
3.9
ph
7.4
7.4
0.58
18
127
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
336
2781
1.25
3.35
5.5
3.1
mmol/l
2.5
2.5
19.71
309
2381
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
57
913
0.61
3.34
1.5
1.7
g/l
1.9
1.5
2.14
47
765
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
89
2.37
3.32
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
58
923
0.62
3.31
2.9
3.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
24
489
0.48
3.24
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
145
1078
1.37
3.19
3.9
3.8
mmol/l
2.4
1.9
1.17
121
777
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
63
398
1.60
3.13
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
63
398
1.60
3.13
1.3
1.4
—
—
—
0
0
(3000492) Spirometry study
120
868
1.41
3.11
1.6
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
151
1137
1.36
3.08
4.0
3.8
kpa
5.4
5.1
2.48
142
1043
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
116
838
1.41
3.04
7.4
9.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
789
0.61
2.97
4.4
3.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
48
775
0.61
2.94
3.0
2.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
88
2.29
2.94
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
113
818
1.40
2.93
4.2
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
110
1500
0.72
2.91
1.2
1.2
iu/ml
74.1
41.5
0.55
24
469
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
108
2.14
2.91
1.7
1.5
—
—
—
0
0
(4094501)
10
276
0.36
2.88
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
454
5199
0.83
2.86
3.0
3.3
ng/l
1484.7
2294.6
6.96
415
4502
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
222
0.36
2.78
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
29
152
1.92
2.75
1.0
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
26
132
1.98
2.70
1.5
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
426
3692
1.20
2.69
4.7
3.0
u/l
29.2
35.5
2.90
414
3486
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
154
1.90
2.66
1.0
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
202
0.34
2.65
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
121
1600
0.74
2.65
1.3
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
36
606
0.59
2.64
1.6
3.3
mg/l
73.0
71.4
0.03
25
484
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
36
606
0.59
2.64
1.6
3.3
mg/l
28.8
78.1
1.51
25
489
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
769
7007
1.16
2.63
10.5
6.0
umol/l
9.5
13.2
12.27
751
6605
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
29
155
1.88
2.61
1.0
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
35
592
0.58
2.61
1.6
3.3
—
2.0
—
0
46
(3023520) Reticulocytes [#/volume] in Blood
123
1619
0.74
2.61
1.9
2.5
e9/l
71.0
66.7
0.63
90
1268
(3003694) ABO and Rh group [Type] in Blood
239
2886
0.80
2.57
1.3
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
63
926
0.67
2.56
1.7
2.1
ug/g
223.3
167.0
0.35
49
733
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
182
0.33
2.52
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
68
463
1.49
2.48
1.4
1.7
—
—
—
0
0
(3019977) pH of Arterial blood
22
109
2.03
2.46
2.1
3.0
ph
7.4
7.4
—
9
38
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
1101
0.71
2.42
2.8
4.0
ng/l
68.6
103.5
4.24
65
927
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
224
0.40
2.42
1.1
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
34
2.95
2.41
1.2
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
774
7090
1.15
2.41
8.0
7.0
mmol/l
1.2
1.2
8.05
665
5885
(3006653) Thiamine [Moles/volume] in Blood
0
66
0.00
2.40
0.0
1.1
—
133.3
—
0
66
(3006184) Hemoglobin [Mass/volume] in Capillary blood
58
385
1.52
2.40
2.1
2.3
g/l
121.8
126.7
0.68
32
279
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
382
3312
1.19
2.39
2.5
2.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
11
265
0.41
2.38
1.6
1.2
mg/l
665.5
589.7
0.24
11
247
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
333
0.48
2.37
1.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
92
1244
0.73
2.35
3.4
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
56
371
1.52
2.34
2.5
3.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
511
0.58
2.33
2.2
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
19
91
2.10
2.33
5.3
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
155
1.82
2.30
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
28
156
1.81
2.26
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
156
1.81
2.26
1.0
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
62
0.00
2.22
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
62
0.00
2.22
0.0
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
708
6474
1.15
2.22
8.8
12.2
inr
1.3
1.4
3.55
164
1729
(3003327) Ova and parasites identified in Stool by Light microscopy
13
284
0.45
2.22
1.8
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
137
1072
1.30
2.21
9.8
6.4
mmol/l
25.7
24.3
3.69
130
1006
(3034770) Mitochondria Ab [Titer] in Serum
13
283
0.46
2.20
1.2
1.2
—
1380.0
—
0
8
(3004809) Band form neutrophils/100 leukocytes in Blood
44
284
1.56
2.09
2.4
3.8
%
1.4
1.6
0.15
38
217
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
470
0.59
2.09
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
35
556
0.62
2.09
1.5
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
209
1733
1.23
2.09
1.5
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
382
3351
1.17
2.08
5.0
4.1
%
87.5
79.8
7.97
377
3256
(3014111) Lactate [Moles/volume] in Serum or Plasma
177
1442
1.25
2.08
5.1
6.1
mmol/l
1.4
1.5
0.48
171
1363
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
303
0.49
2.08
1.1
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
407
4589
0.86
2.06
3.2
3.6
e6/l
107.0
114.6
0.06
343
3686
(3043409) Potassium [Moles/volume] in Arterial blood
71
508
1.41
2.05
6.6
4.0
mmol/l
4.0
4.0
0.40
65
461
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
328
0.51
2.05
1.6
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
62
868
0.70
1.99
3.1
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
182
2191
0.81
1.92
2.4
2.3
%
1.7
1.8
0.16
156
1911
(3000991) Gas panel - Venous blood
167
1374
1.24
1.82
5.5
7.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
87
662
1.33
1.76
4.8
4.2
mmol/l
25.7
24.8
1.75
82
605
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
95
1.90
1.75
3.2
3.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
38
563
0.67
1.69
1.7
2.9
g/l
0.2
0.3
0.66
19
234
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
11
228
0.48
1.68
1.5
1.2
mmol/l
3.9
4.0
0.11
11
205
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
214
2496
0.84
1.64
2.9
3.0
e6/l
0.8
1.1
1.10
129
1519
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
146
0.41
1.64
1.7
1.5
—
—
—
0
0
(4024509)
5
131
0.38
1.62
1.6
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
43
2.33
1.60
1.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
17
300
0.56
1.59
3.0
2.3
—
—
—
0
0
(4146454)
8
175
0.45
1.57
2.8
2.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
389
4317
0.88
1.55
2.1
2.2
u/l
170.8
263.1
1.90
370
4002
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
157
0.44
1.55
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
15
3.34
1.52
1.2
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
27
2.60
1.51
1.1
2.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
125
0.40
1.50
1.2
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
126
0.40
1.50
1.0
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
45
0.00
1.49
0.0
1.2
—
14.6
—
0
33
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
15
79
1.91
1.49
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
133
1095
1.23
1.48
2.9
3.9
%
1.1
0.9
0.71
74
387
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
37
2.44
1.48
1.2
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
474
4326
1.13
1.46
2.6
2.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
66
498
1.34
1.46
3.0
3.4
mmol/l
25.6
24.8
0.79
56
437
(40767503) Oxygen content in Capillary blood by calculation
50
363
1.39
1.41
3.0
2.8
%
14.7
15.6
0.82
25
183
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
173
1.57
1.40
1.7
3.8
%
55.5
57.9
0.24
21
110
(3044290) Cell count panel - Cerebral spinal fluid
10
199
0.50
1.40
1.7
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
233
2032
1.17
1.40
6.8
6.4
mmol/l
103.3
104.4
2.76
225
1972
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
57
424
1.35
1.39
1.2
1.1
iu/ml
52.6
137.1
1.64
11
140
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
39
0.00
1.33
0.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
27
405
0.66
1.33
1.2
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
463
0.69
1.32
1.6
3.4
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
41
0.00
1.31
0.0
1.5
—
94.7
—
0
34
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
18
2.78
1.28
6.0
16.5
nmol/l
2609.6
1488.9
—
5
18
(3001019) Free T4 and TSH panel - Serum or Plasma
6
134
0.45
1.27
1.2
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
459
0.69
1.27
1.5
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
123
1024
1.21
1.26
3.0
4.0
%
0.2
0.1
0.25
66
356
(3015377) Calcium [Moles/volume] in Serum or Plasma
495
4566
1.11
1.26
5.1
3.2
mmol/l
2.4
2.3
8.60
460
3850
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
328
0.64
1.26
1.0
1.5
ug/g
188.3
260.1
1.05
12
212
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
127
1511
0.83
1.26
2.0
2.7
umol/l
6.8
11.6
1.96
109
1331
(21494815) CD4 cells/100 lymphocytes in Specimen
13
70
1.86
1.24
1.3
2.1
—
42.2
—
0
10
(3019832) Treponema pallidum Ab [Presence] in Serum
16
265
0.60
1.23
1.1
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
213
2419
0.87
1.21
2.9
3.3
e6/l
3.2
1.3
1.12
128
1449
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
82
657
1.26
1.21
2.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
143
0.49
1.20
1.1
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
28
407
0.68
1.20
4.2
3.8
mmol/l
1.8
1.7
0.13
28
399
(3000850) Epithelial cells [#/volume] in Urine
294
3266
0.88
1.20
2.5
2.8
e6/l
5.5
3.7
2.03
265
2894
(21494434) Karyotype in Bone marrow
9
169
0.53
1.18
1.0
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
115
959
1.21
1.18
2.8
3.8
%
0.5
0.6
0.23
49
264
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
199
0.55
1.17
2.4
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
57
1.94
1.17
2.5
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
57
1.94
1.17
2.5
2.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
61
473
1.30
1.16
5.5
3.2
pmol/l
4.4
4.3
0.31
56
405
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
50
2.01
1.16
1.1
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
42
565
0.74
1.16
2.1
3.0
u/ml
24.5
7703.6
0.92
33
478
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
33
0.00
1.16
0.0
1.6
—
24.8
—
0
27
(3029075) Extractable nuclear Ab panel - Serum
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
33
0.00
1.16
0.0
1.2
—
27.4
—
0
5
(3018405) Lactate [Moles/volume] in Arterial blood
77
616
1.26
1.16
6.2
3.8
mmol/l
1.3
1.5
1.20
77
606
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
235
0.59
1.15
1.2
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
356
3897
0.89
1.14
3.1
3.5
—
—
—
0
0
(3017704) Immunofixation for Urine
5
111
0.45
1.13
1.2
1.5
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
11
58
1.90
1.12
1.5
1.2
%
29.8
22.1
0.34
11
43
(21494814) CD8 cells/100 lymphocytes in Specimen
7
31
2.26
1.10
1.1
2.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
62
782
0.79
1.09
5.1
3.2
e9/l
4.9
4.3
0.77
41
541
(21494755) Public health laboratory ask at order entry panel
14
231
0.60
1.08
1.2
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
218
0.59
1.07
1.2
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
15
89
1.69
1.07
2.2
2.2
e9/l
0.9
0.9
—
9
48
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
88
723
1.23
1.06
2.1
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
27
384
0.70
1.06
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
217
0.60
1.06
1.4
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
72
888
0.80
1.05
1.5
1.7
%
1.9
1.7
0.65
54
707
(1761482) Bacteria [#/volume] in Urine by Culture
35
474
0.73
1.03
4.6
4.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
13
215
0.60
1.03
2.9
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
773
8115
0.92
1.02
6.8
5.0
mmol/l
6.9
7.0
0.32
753
7652
(3022806) Fractional oxyhemoglobin in Capillary blood
32
230
1.40
1.01
2.3
2.0
%
86.5
88.7
0.55
32
230
(3051611) Lipemic interference index of Serum or Plasma
23
155
1.49
1.01
5.0
3.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
27
379
0.71
1.00
4.3
3.9
mmol/l
7.0
7.8
1.92
27
371
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
367
0.70
0.99
1.2
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
137
1579
0.86
0.98
2.8
3.1
ng/l
176.9
303.9
6.22
128
1448
(42529406) Shigella sp [Presence] in Stool by Culture
23
331
0.69
0.98
1.2
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
161
0.56
0.98
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
378
4089
0.91
0.97
3.0
3.5
e6/l
0.7
0.5
0.51
312
3221
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
20
295
0.67
0.97
1.5
1.3
g/l
1.2
1.1
0.12
20
281
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
198
0.60
0.95
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
329
0.70
0.95
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
32
0.00
0.95
0.0
8.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
327
0.70
0.92
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
140
1602
0.86
0.92
4.9
3.9
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
182
0.60
0.89
2.0
2.2
u/ml
3.1
246.0
0.58
11
177
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
67
810
0.82
0.85
4.4
4.2
%
50.4
46.8
0.66
67
798
(3041918) Cholesterol [Moles/volume] in Pleural fluid
8
45
1.78
0.84
1.1
1.1
mmol/l
1.4
1.4
—
8
33
(3017143) Hepatitis C virus Ab [Presence] in Serum
74
885
0.83
0.84
1.2
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
20
285
0.70
0.83
1.4
1.3
g/l
0.2
0.2
0.60
20
271
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
139
0.57
0.83
1.0
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
105
1216
0.86
0.83
1.3
1.3
titre
484.3
448.0
0.11
28
279
(3021589) Normoblasts [#/volume] in Blood
490
5200
0.92
0.82
14.1
10.8
e9/l
0.0
0.0
0.99
399
4186
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
24
0.00
0.79
0.0
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
33
1.82
0.79
3.5
1.7
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
25
0.00
0.79
0.0
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
76
900
0.84
0.79
1.3
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
26
0.00
0.78
0.0
1.0
—
1569.9
—
0
26
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
35
451
0.77
0.78
1.2
1.7
u/l
34.6
37.8
0.44
30
378
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
27
0.00
0.77
0.0
8.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
116
1324
0.87
0.77
3.2
3.0
kpa
4.6
4.4
0.38
110
1258
(21494890) Protein electrophoresis panel - 24 hour Urine
11
174
0.63
0.76
1.0
2.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
132
1.44
0.76
1.5
1.6
g/l
0.7
1.0
1.09
14
101
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
10
161
0.62
0.75
1.5
1.9
u/field
1.0
2.0
—
5
55
(4015189)
9
54
1.67
0.74
1.3
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
571
5999
0.93
0.73
4.4
4.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
55
1.64
0.73
1.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
55
1.64
0.73
1.2
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
34
263
1.30
0.73
1.2
1.3
mmol/l
59.4
63.6
0.30
27
212
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
100
1.50
0.73
1.1
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
441
4158
1.08
0.71
5.0
2.5
u/l
56.0
58.8
0.69
424
3807
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
40
1.75
0.71
1.4
1.8
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
30
229
1.31
0.71
8.9
8.4
mmol/l
7.1
7.5
0.26
24
190
(3045424) Erythrocytes [Presence] in Urine
11
170
0.65
0.70
1.2
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
597
0.82
0.70
1.2
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
101
1.49
0.70
1.1
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
58
1.55
0.69
1.2
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
107
939
1.15
0.68
3.1
4.0
%
0.0
0.4
0.74
59
293
(3008295) Osmolality of Serum or Plasma
19
136
1.40
0.66
1.4
1.3
mosm/kgh2o
279.9
278.0
0.14
14
94
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
286
1.26
0.65
1.3
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
11
70
1.57
0.65
1.0
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
11
70
1.57
0.65
1.0
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
11
70
1.57
0.65
2.7
2.9
u/l
189.5
209.9
0.53
11
70
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
33
416
0.79
0.65
2.3
2.4
ug/min
87.3
92.3
0.04
17
248
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
201
0.69
0.64
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
132
1182
1.13
0.63
4.2
4.0
mmol/l
1.2
1.2
2.93
124
1019
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
535
0.82
0.63
1.1
1.2
—
—
—
0
0
(4062490)
12
79
1.52
0.62
1.4
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
103
0.58
0.62
1.7
1.8
%
12.3
10.4
—
6
103
(3051387) C reactive protein [Mass/volume] in Capillary blood
29
368
0.78
0.61
4.0
3.9
mg/l
48.3
31.7
1.09
23
252
(40760892) CBC W Ordered Manual Differential panel - Blood
250
2320
1.09
0.61
5.8
4.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
152
0.66
0.61
1.1
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
21
0.00
0.60
0.0
8.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
22
0.00
0.59
0.0
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
243
0.74
0.59
1.1
1.3
nmol/l
1.8
0.8
0.61
12
196
(3003458) Phosphate [Moles/volume] in Serum or Plasma
192
2087
0.91
0.59
4.6
5.6
mmol/l
1.0
1.0
2.32
182
1894
(3007853) Bacteria identified in Skin by Aerobe culture
146
1609
0.90
0.59
1.7
1.8
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
11
72
1.53
0.59
1.2
1.1
u/l
125.5
118.6
0.05
11
62
(3028271) Lactate [Moles/volume] in Capillary blood
35
282
1.25
0.58
2.3
2.1
mmol/l
1.7
1.7
0.20
35
276
(3047181) Lactate [Moles/volume] in Blood
57
484
1.18
0.57
7.7
5.8
mmol/l
1.0
1.5
5.75
50
425
(3000475) Leukocytes [#/volume] in Synovial fluid
26
331
0.78
0.57
1.3
1.6
e6/l
83356.7
17672.7
0.61
19
236
(3028433) Virus identified in Specimen by Culture
6
36
1.67
0.56
1.2
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
97
1088
0.89
0.54
4.0
4.2
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
6
38
1.58
0.54
1.2
1.1
mmol/l
0.6
1.1
—
6
29
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
61
1.48
0.53
1.2
2.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
62
1.45
0.53
1.7
1.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
9
63
1.43
0.52
1.2
2.4
%
72.6
71.0
—
9
56
(3021447) Carbon dioxide [Partial pressure] in Venous blood
147
1605
0.91
0.51
3.1
3.6
kpa
6.1
5.8
1.88
142
1537
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
117
1058
1.11
0.51
1.6
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
32
261
1.23
0.50
1.2
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
10
67
1.50
0.49
4.3
3.5
%
59.2
53.5
—
10
62
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
45
1.56
0.49
2.9
2.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
147
1598
0.91
0.48
3.1
3.7
mmol/l
2.8
1.9
2.14
126
1230
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
47
1.49
0.47
1.3
1.8
nmol/l
12.4
15.5
—
7
41
(3020779) Urea [Moles/volume] in Serum or Plasma
168
1554
1.09
0.47
3.5
6.7
mmol/l
9.3
12.3
5.59
158
1448
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
558
0.86
0.46
1.0
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
81
0.62
0.45
2.0
1.5
u/l
5.0
10.5
—
5
40
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
83
0.60
0.45
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
12
164
0.73
0.45
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
17
219
0.77
0.43
1.1
1.1
—
—
—
0
0
(4034850)
31
372
0.83
0.43
13.6
14.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
78
871
0.89
0.43
3.8
3.6
mmol/l
27.0
24.9
4.77
78
846
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
127
0.71
0.43
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
14
104
1.35
0.43
1.3
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
11
78
1.41
0.43
1.5
1.2
g/l
2.8
2.7
—
6
58
(3027135) IgG subclass 1 [Mass/volume] in Serum
11
78
1.41
0.43
1.5
1.2
g/l
7.4
7.3
—
6
58
(3000494) Fungus identified in Specimen by Culture
151
1398
1.09
0.43
1.3
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
32
1.56
0.42
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
338
0.83
0.42
2.5
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
323
1.18
0.41
1.3
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
15
0.00
0.41
0.0
1.5
—
15.0
—
0
9
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.3
—
16.6
—
0
15
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3020891) Body temperature
74
662
1.12
0.41
7.7
4.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
16
0.00
0.41
0.0
1.8
—
66.5
—
0
10
(3035933) Granulocytes/100 leukocytes in Blood
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.1
—
110.9
—
0
9
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
101
0.69
0.39
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
98
1.33
0.37
1.8
2.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
134
1.27
0.37
1.6
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
147
1574
0.93
0.36
2.2
2.6
ug/l
6.1
6.7
0.16
130
1335
(4268621)
5
78
0.64
0.35
2.0
2.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
28
330
0.85
0.34
1.9
2.5
umol/l
41.0
32.7
0.77
22
276
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
286
0.84
0.33
1.7
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
221
0.81
0.33
3.0
2.3
mg/l
36.1
21.9
—
8
46
(3044941) Cell count panel - Synovial fluid
17
210
0.81
0.33
1.1
1.4
—
—
—
0
0
(3019225) pH of Specimen
139
1484
0.93
0.33
5.0
4.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
164
1.22
0.32
2.4
2.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
10
74
1.35
0.32
2.7
1.8
e6/l
338.8
666.2
—
5
32
(4306422)
7
100
0.70
0.30
1.0
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
632
6169
1.04
0.30
5.8
4.8
g/l
31.8
33.9
14.02
603
5623
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
268
1.16
0.30
1.1
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
300
3116
0.96
0.29
2.6
3.0
mosm/kgh2o
546.5
569.6
1.38
261
2665
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
124
1321
0.93
0.29
1.7
2.1
g/l
0.2
0.2
0.33
116
1207
(3016018) Differential panel - Cerebral spinal fluid
8
106
0.75
0.29
1.6
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
108
0.74
0.29
1.8
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
24
204
1.18
0.28
1.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
1.0
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
110
1174
0.93
0.27
2.8
2.4
u/l
35.0
36.9
0.10
99
973
(3021788) Differential panel - Synovial fluid
22
258
0.85
0.27
1.2
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
139
1464
0.95
0.24
1.7
2.6
g/l
65.6
65.7
0.04
128
1309
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
81
0.74
0.24
2.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
94
0.74
0.22
1.0
1.1
%
124.0
110.0
—
7
86
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.5
—
92.9
—
0
11
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.0
—
15.2
—
0
11
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
11
0.00
0.21
0.0
1.1
—
81.0
—
0
6
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.1
—
81.0
—
0
5
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
5.9
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.7
—
109.1
—
0
14
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
48
1.25
0.20
1.3
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
21
239
0.88
0.19
1.3
1.2
u/ml
3.4
2.9
—
7
31
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
164
0.85
0.18
1.2
1.4
%
73.8
65.9
—
9
107
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
119
1137
1.05
0.18
1.5
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
22
247
0.89
0.17
3.0
2.9
mmol/l
105.5
105.8
0.08
22
242
(3041354) Potassium [Moles/volume] in Venous blood
22
247
0.89
0.17
3.0
2.9
mmol/l
4.1
4.1
0.18
22
242
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
33
360
0.92
0.16
1.2
1.3
—
7.6
—
0
6
(3024263) Appearance of Synovial fluid
6
78
0.77
0.15
1.2
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
119
0.84
0.15
1.8
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
82
1.10
0.15
1.4
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
88
0.79
0.14
3.3
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
242
0.91
0.13
3.0
2.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
48
452
1.06
0.13
4.7
3.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
110
0.82
0.13
8.4
16.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
11
127
0.87
0.12
1.0
1.2
nmol/l
—
0.5
—
0
7
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
317
1.07
0.12
1.6
1.5
iu/ml
3.8
16.7
—
8
76
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
94
906
1.04
0.11
1.3
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
80
770
1.04
0.10
3.0
2.6
%
1.6
1.1
2.82
80
764
(3010375) cycloSPORINE [Mass/volume] in Blood
5
44
1.14
0.10
12.0
26.9
ug/l
121.6
117.6
—
5
38
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
45
1.11
0.09
1.0
1.2
iu/ml
117.0
223.4
—
5
45
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
65
1.08
0.08
1.3
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
205
0.93
0.08
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
72
0.83
0.07
1.3
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
6
75
0.80
0.07
1.0
1.1
%
95.3
96.3
—
6
70
(3047189) Immunofixation for 24 hour Urine
7
82
0.85
0.07
1.0
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
299
2954
1.01
0.07
5.0
4.2
ng/l
268.8
437.8
0.45
265
2632
(40757494) Bilirubin.total [Moles/volume] in Blood
7
85
0.82
0.07
1.0
1.9
—
29.4
—
0
10
(3038177) Helicobacter pylori Ab [Presence] in Serum
9
105
0.86
0.06
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
197
1.07
0.06
1.2
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
10
90
1.11
0.05
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
248
2507
0.99
0.05
1.5
1.6
mg/l
1.3
1.7
1.40
206
1987
(3019230) Fractional oxyhemoglobin in Venous blood
25
238
1.05
0.05
3.6
2.2
%
68.5
60.4
0.91
25
238
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
189
1.06
0.04
1.3
2.4
u/ml
—
1878.3
—
0
20
(3026389) Candida sp identified in Specimen by Organism specific culture
12
130
0.92
0.04
1.2
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
74
752
0.98
0.03
3.0
2.6
%
0.7
0.7
0.54
74
722
(3014271) Vancomycin [Susceptibility]
12
112
1.07
0.03
3.0
3.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
118
0.93
0.02
1.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
103
1018
1.01
0.02
5.8
3.1
ml/min/173m2
62.8
57.8
0.79
41
452
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
31
316
0.98
0.00
1.4
2.1
%
88.9
84.7
0.37
31
301
(3000093) Morphology [Interpretation] in Blood Narrative
16
165
0.97
0.00
1.0
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
43
425
1.01
0.00
2.8
3.0
nmol/l
0.8
0.9
0.44
37
318
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
1025
0.99
0.00
1.3
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
114
0.96
0.00
1.0
1.2
nmol/l
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
103
0.97
0.00
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
113
0.97
0.00
1.7
2.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
93
0.97
0.00
2.1
2.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
55
0.91
0.00
1.2
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
189.6
—
0
5
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
2.2
—
0
5
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
382.0
—
0
5
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
2.4
6.5
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
4.9
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
88
0.91
0.00
1.0
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
6.9
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.8
—
18.8
—
0
6
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(44813793)
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
79
1.01
0.00
1.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4281824)
8
86
0.93
0.00
1.1
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
1.4
u/l
5.4
9.4
—
5
44
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
85.9
—
0
8
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
24.7
—
0
7
(3032773) Endomysium IgG Ab [Titer] in Serum
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
51
0.98
0.00
1.0
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
98.7
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
-0.00
0.0
6.3
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_NSCLC_SQUAM – Non-small cell lung cancer, squamous, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).